Literature DB >> 15098926

Developmental changes in insulin-like growth factor I receptor gene expression in the mouse mammary gland.

Geetanjalee Modha1, Anne Blanchard, Barbara Iwasiow, Xiao Juan Mao, Sandra Troup, Adewale Adeyinka, Peter Watson, Robert Shiu, Yvonne Myal.   

Abstract

The insulin-like growth factor I receptor (IGF-IR), which mediates the mitogenic action of IGF-I, has been shown to play an essential role in normal growth and development. However, the precise role of IGF-IR in the growth and differentiation of the mammary gland has not been elucidated. This study examines the profile of the IGF-IR gene and protein expression during normal postnatal mammary gland development in order to gain further insight into the role of the IGF-I/IGF-IR during mammary gland morphogenesis. Gene and protein expression were examined in developing mouse mammary glands (virgin, pregnant, lactating, involuting) by real time PCR analysis and Western blotting. Both IGF-IR gene and protein expression levels were high during early pregnancy. Interestingly, the level of gene expression was significantly down-regulated during late pregnancy (5.4 fold) and lactation (9-13 fold) and significantly up-regulated (3.9 fold) during late involution, to the level observed in the virgin mammary gland. By in situ hybridization, the IGF-IR transcripts were localized to the proliferating ductal epithelium of the mammary glands of virgin mice and to the differentiating ductal and alveolar epithelium of the mammary glands during pregnancy and lactation. In the involuting gland, the transcripts were localized to the regressing ductal epithelium. These data are direct evidence that IGF-IR expression is important for alveolar cell proliferation and suggest that the progression of involution may require the down-regulation of IGF-IR gene expression. Altogether, these results demonstrate that a developmental IGF-IR gene expression pattern exists in the mouse mammary gland and that increases in gene expression at specific phases of development may reflect an important role for IGF-I/IGF-IR at those phases of development.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15098926     DOI: 10.1081/erc-120029892

Source DB:  PubMed          Journal:  Endocr Res        ISSN: 0743-5800            Impact factor:   1.720


  5 in total

Review 1.  Growth hormone and insulin-like growth factor-I in the transition from normal mammary development to preneoplastic mammary lesions.

Authors:  David L Kleinberg; Teresa L Wood; Priscilla A Furth; Adrian V Lee
Journal:  Endocr Rev       Date:  2008-12-15       Impact factor: 19.871

2.  Insulin-like growth factor type 1 receptor and insulin receptor isoform expression and signaling in mammary epithelial cells.

Authors:  Anne M Rowzee; Dale L Ludwig; Teresa L Wood
Journal:  Endocrinology       Date:  2009-04-30       Impact factor: 4.736

Review 3.  IGF ligand and receptor regulation of mammary development.

Authors:  Anne M Rowzee; Deborah A Lazzarino; Lauren Rota; Zhaoyu Sun; Teresa L Wood
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-11-20       Impact factor: 2.673

4.  The miR-424(322)/503 cluster orchestrates remodeling of the epithelium in the involuting mammary gland.

Authors:  David Llobet-Navas; Ruth Rodríguez-Barrueco; Verónica Castro; Alejandro P Ugalde; Pavel Sumazin; Damian Jacob-Sendler; Berna Demircan; Mireia Castillo-Martín; Preeti Putcha; Netonia Marshall; Patricia Villagrasa; Joseph Chan; Félix Sanchez-Garcia; Dana Pe'er; Raul Rabadán; Antonio Iavarone; Carlos Cordón-Cardó; Andrea Califano; Carlos López-Otín; Elena Ezhkova; Jose M Silva
Journal:  Genes Dev       Date:  2014-03-17       Impact factor: 11.361

5.  Fenugreek Stimulates the Expression of Genes Involved in Milk Synthesis and Milk Flow through Modulation of Insulin/GH/IGF-1 Axis and Oxytocin Secretion.

Authors:  Thomas Sevrin; Clair-Yves Boquien; Alexis Gandon; Isabelle Grit; Pierre de Coppet; Dominique Darmaun; Marie-Cécile Alexandre-Gouabau
Journal:  Genes (Basel)       Date:  2020-10-16       Impact factor: 4.096

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.